Compounding Pharmacy’s Pricing Drives $1.2M False Claims Pact

Oct. 3, 2018, 8:02 PM

A steep price difference between what a compounding pharmacy charged TRICARE and its cash-paying customers proved sufficient for federal prosecutors to negotiate a $1.2 million settlement—in what one health-care attorney called a novel civil prosecution strategy.

The now-defunct Florida pharmacy, RS Compounding LLC, and its owner Renier Gobea agreed to pay $1.2 million to settle allegations originally brought in a 2013 whistleblower lawsuit. The federal government intervened on some of the allegations in 2017.

The case shows “the government is willing to bring aggressive enforcement action just based on a price differential,” said Ryan Stumphauzer, a white-collar crime attorney ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.